U.S. study faults aggressive end-of-life cancer care

Key points
- One third of U.S. patients dying of cancer end up getting costly but futile treatment in hospitals, when hospice care to ease their suffering would be more appropriate, researchers reported on Tuesday.
- President Barack Obama's signature program, healthcare reform, is under fire from Republicans about to take control of the House of Representatives who say it does not do enough to control costs, as well as by left-wing Democrats who say it did not go far enough but who also want to control costs.
- The Dartmouth Atlas, a project that studies and documents variations in medical care across the United States, also found that where cancer patients live may decide the way they die: in an emergency room or at home.
- The latest study finds that 29 percent of patients with advanced cancer died in a hospital between 2003 and 2007.
One third of U.S. patients dying of cancer end up getting costly but futile treatment in hospitals, when hospice care to ease their suffering would be more appropriate, researchers reported on Tuesday.
The Dartmouth Atlas, a project that studies and documents variations in medical care across the United States, also found that where cancer patients live may decide the way they die: in an emergency room or at home.
The latest study finds that 29 percent of patients with advanced cancer died in a hospital between 2003 and 2007.
Last-ditch treatment of dying patients is expensive, upsetting to families and adds to suffering in many cases, cancer experts agree. They get feeding and breathing tubes and are often resuscitated repeatedly.
"Patients often unnecessarily receive care in the ICU and invasive procedures," said Dr. John Goodman who coauthored the Dartmouth Atlas study of 235,821 patients with federal Medicare health insurance who died of cancer between 2003 and 2007.
"On average, patients ... would much prefer to receive care that allows them the highest quality of life in their last weeks and months and care that allows them whenever possible to be at home and with their families," Goodman told reporters in a telephone briefing.
The report, available at www.dartmouthatlas.org, shows a lack of planning about how to treat fatal cancer, which is the second leading cause of death in developed countries and will kill more than 500,000 Americans this year.
The study found that cancer care at the end of life varies markedly from region to region and from hospital to hospital.
"I think that the care patients receive has less to do with what they want and more to do with the hospital they happen to seek care from," Goodman said.
"In some healthcare systems, patients with advanced cancer have a greater chance of spending their last weeks and months in hospitals," he added. "Geography is destiny."
New York's borough of Manhattan had the most cancer deaths in-hospital - 46.7 percent, compared with Mason City, Iowa, where 7 percent of cancer patients died in the hospital.
The issue affects the bottom line. The United States spent $2.3 trillion on healthcare in 2008 - $7,681 per resident, accounting for 16 percent of gross domestic product or GDP. Studies have shown about 31 percent of this - by far the biggest single share - is spent in hospitals.
INFORMING HEALTHCARE REFORM
President Barack Obama's signature program, healthcare reform, is under fire from Republicans about to take control of the House of Representatives who say it does not do enough to control costs, as well as by left-wing Democrats who say it did not go far enough but who also want to control costs.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsTrastuzumab continues to show life for HER2-positve early stage breast cancer
After following breast cancer patients for an average of eight-plus years, researchers say that adding trastuzumab (Herceptin) to chemotherapy significantly improved the overall and disease-free survival of women with…
22 October 2014
NewsResearchers discover gene that can predict aggressive prostate cancer at diagnosis
Researchers at The University of Texas MD Anderson Cancer Center have identified a biomarker living next door to the KLK3 gene that can predict which GS7 prostate cancer patients will have a more aggressive form of…
4 October 2014
NewsPatients with advanced, incurable cancer denied palliative care
Many patients with advanced, incurable cancer do not receive any palliative care, reveals new research to be presented later this month at the ESMO 2014 Congress in Madrid, Spain, 26-30 September. The findings are…






